Lethal giant larvae 1 inhibits smooth muscle calcification via high mobility group box 1. 2020

Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.

Vascular calcification is a pathological process closely related to atherosclerosis, diabetic vascular diseases, vascular injury, hypertension, chronic kidney disease and aging. Lethal giant larvae 1 (LGL1) is known as a key regulator of cell polarity and plays an important role in tumorigenesis. However, whether LGL1 regulates vascular calcification remains unclear. In this study, we generated smooth muscle-specific LGL1 knockout (LGL1SMKO) mice by cross-breeding LGL1flox/flox mice with α-SMA-Cre mice. LGL1 level was significantly decreased during calcifying conditions. Overexpression of LGL1 restrained high phosphate-induced calcification in vascular smooth muscle cells (VSMCs). Mechanically, LGL1 could bind with high mobility group box 1 (HMGB1) and promote its degradation via the lysosomal pathway, thereby inhibiting calcification. Smooth muscle-specific deletion of LGL1 increased HMGB1 level and aggravated vitamin D3-induced vascular calcification, which was attenuated by an HMGB1 inhibitor. LGL1 may inhibit vascular calcification by preventing osteogenic differentiation via promoting HMGB1 degradation.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
December 2013, Inflammation,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
July 2020, Journal of clinical laboratory analysis,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
January 2017, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
April 2021, Journal of cellular and molecular medicine,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
March 2012, Molecular biology reports,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
January 2022, Frontiers in pharmacology,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
January 2018, The Journal of experimental medicine,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
March 2017, Journal of cellular biochemistry,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
December 2005, Critical care medicine,
Tianran Zhang, and Guangqing Cao, and Xiao Meng, and Changhan Ouyang, and Jiangang Gao, and Yuanyuan Sun, and Jiliang Wu, and Qing Min, and Cheng Zhang, and Wencheng Zhang
May 2017, Molecular medicine reports,
Copied contents to your clipboard!